Yihan Feng
Overview
Explore the profile of Yihan Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Muro F, Sartori S, Vogel B, Feng Y, Gitto M, Oliva A, et al.
Clin Res Cardiol
. 2025 Feb;
PMID: 39998662
Background: Chronic kidney disease (CKD) is associated with unfavorable outcomes in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). However, its prognostic role in patients undergoing complex...
2.
Kunadian V, Gitto M, Vogel B, Sartori S, Angiolillo D, Bhatt D, et al.
JACC Cardiovasc Interv
. 2025 Feb;
PMID: 39969452
Background: In patients at high bleeding risk (HBR), short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is associated with reduced bleeding and preserved ischemic protection. Objectives: The aim...
3.
Steg P, Nicolas J, Baber U, Sartori S, Zhang Z, Feng Y, et al.
Am Heart J
. 2025 Jan;
PMID: 39889917
Background: The TWILIGHT trial showed that, among high-risk patients who underwent percutaneous coronary intervention (PCI) and were event-free at 3 months, ticagrelor monotherapy versus ticagrelor plus aspirin reduced bleeding without...
4.
Bay B, Gitto M, Sartori S, Vogel B, Tchetche D, Petronio A, et al.
Catheter Cardiovasc Interv
. 2025 Jan;
105(4):891-899.
PMID: 39776285
Background: Limited data exist on the impact of polyvascular disease (PolyVD) on clinical outcomes in female patients undergoing transcatheter aortic valve replacement (TAVR). We therefore sought to investigate clinical outcomes...
5.
Di Muro F, Vogel B, Sartori S, Tchetche D, Feng Y, Petronio A, et al.
Am J Cardiol
. 2024 Nov;
236():56-63.
PMID: 39522578
Limited evidence exists concerning the prognostic impact of baseline left ventricular ejection fraction (LVEF) on outcomes among women undergoing transcatheter aortic valve implantation (TAVI), which we aimed to investigate in...
6.
Cheng X, Yang X, Guan Y, Feng Y
Comput Biol Med
. 2024 Aug;
180:109012.
PMID: 39153394
In drug discovery, precisely identifying drug-target interactions is crucial for finding new drugs and understanding drug mechanisms. Evolving drug/target heterogeneous data presents challenges in obtaining multimodal representation in drug-target prediction(DTI)....
7.
Spirito A, Sartori S, Koshy A, Feng Y, Vogel B, Baber U, et al.
J Am Coll Cardiol
. 2024 Jul;
84(5):467-477.
PMID: 39048279
Background: It remains unclear whether procedural myocardial infarction (pMI) and spontaneous myocardial infarction (spMI) have a similar impact on prognosis. Objectives: The aim of this study was to assess mortality...
8.
Mankerious N, Toelg R, Vogel B, Sartori S, Angiolillo D, Vranckx P, et al.
Am J Cardiol
. 2024 Jun;
225():25-34.
PMID: 38871156
Shortening the duration of dual-antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) was shown to be effective and safe in patients at high bleeding risk (HBR). We aimed to investigate...
9.
Koshy A, Stone G, Sartori S, Dhulipala V, Giustino G, Spirito A, et al.
J Am Heart Assoc
. 2024 May;
13(11):e033931.
PMID: 38818962
Background: Patients may prefer percutaneous coronary intervention (PCI) over coronary artery bypass graft (CABG) surgery, despite heart team recommendations. The outcomes in such patients have not been examined. We sought...
10.
Cao D, Vranckx P, Valgimigli M, Sartori S, Angiolillo D, Bangalore S, et al.
EuroIntervention
. 2024 May;
20(10):e630-e642.
PMID: 38776146
Background: A short dual antiplatelet therapy (DAPT) duration has been proposed for patients at high bleeding risk (HBR) undergoing drug-eluting coronary stent (DES) implantation. Whether this strategy is safe and...